Cargando…
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice
Although an increasing number of antibody conjugates are being used in the clinic, there remain many unmet needs in antibody targeting. Normal tissue background is one of the key issues that limits the therapeutic efficacy and the detection sensitivity. Background reduction coupled with dose increas...
Autores principales: | Dou, Shuping, Virostko, John, Rusckowski, Mary, Greiner, Dale L., Powers, Alvin C., Liu, Guozheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109569/ https://www.ncbi.nlm.nih.gov/pubmed/25104938 http://dx.doi.org/10.3389/fphar.2014.00172 |
Ejemplares similares
-
The Biotin–Avidin Interaction in Biotinylated Gold Nanoparticles and the Modulation of Their Aggregation
por: Lyu, Yanchao, et al.
Publicado: (2021) -
Clearable nanomaterials
por: Voliani, Valerio, et al.
Publicado: (2018) -
Comparison of the Chase Effects of Avidin, Streptavidin, Neutravidin, and Avidin‐Ferritin on a Radiolabeled Biotinylated Anti‐tumor Monoclonal Antibody
por: Kobayashi, Hisataka, et al.
Publicado: (1995) -
Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
por: Otsuji, E., et al.
Publicado: (1996) -
Decreased Renal Accumulation of Biotinylated Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate after Administration of Avidin
por: Otsuji, Eigo, et al.
Publicado: (1997)